Simon Lord
0000-0001-7946-5609
7 papers found
Refreshing results…
A Phase Ib/II study of IGF-neutralising antibody xentuzumab with enzalutamide in metastatic castration-resistant prostate cancer
Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib
VCAM-1–targeted MRI Improves Detection of the Tumor-brain Interface
The current status of risk-stratified breast screening
Phase 1 study of the ATR inhibitor berzosertib in combination with cisplatin in patients with advanced solid tumours
Transcriptomic analysis of human primary breast cancer identifies fatty acid oxidation as a target for metformin
Window of opportunity clinical trial designs to study cancer metabolism
Missing publications? Search for publications with a matching author name.